Zura Bio Reports Business Updates and Outlook for 2026

Core Viewpoint - Zura Bio Limited is a clinical-stage biotechnology company focused on developing innovative treatments for serious autoimmune and inflammatory diseases, and it has provided business updates along with an outlook for 2026 [1] Business Updates - The company is looking forward to significant developments in 2026, particularly with two potentially transformative readouts for its drug tibulizumab expected within the next 18 months [1]